Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 21 Sep 21 424B3 Prospectus supplement
- 20 Sep 21 EFFECT Notice of effectiveness
-
3 Sep 21 S-3 Shelf registration
RSLS similar filings
Filing view
External links
Exhibit 23.3
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated February 27, 2020, with respect to the consolidated financial statements of Obalon Therapeutics, Inc., incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Diego, California
September 3, 2021